Clinical Trials Arena on MSN6d
MSD to push for approval of HIV combo after Phase III success
MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.
pharmaphorum4d
FDA approves Merck’s Delstrigo and Pifeltro for HIV treatment
Merck, known as MSD outside the United States and Canada announced that the Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo and Pifeltro. The FDA has approved ...
Merck releases positive phase 3 data on daily oral HIV drug
Merck (NYSE:MRK) said that data from a pair of late-stage trials showed that an oral, two-drug regimen of ...